GST Benefits New Revised MRP, 100% GST benefit passed
Torrent Pharmaceuticals Ltd

VIZYLAC GG Sachet 0.75gm

Supplements
Revised GST MRP ₹48.55 21.69% OFF 21.69% OFF (Inclusive of all taxes)
Deliver to

    Netmeds First Membership

    Starting at just ₹[] for 3 months.
    View Plans

    Introduction About VIZYLAC GG SACHET

    Vizylac GG Sachet is a probiotic, used to manage diarrhoea, antibiotic-associated diarrhoea, diarrhea caused by rotavirus (in babies and children) and travellers’ diarrhoea. It is also used to relieve symptoms such as irritable bowel syndrome (IBS), Crohn's disease and ulcerative colitis. Also, it is used to manage colic in babies and atopic dermatitis in children.

    Lactobacillus Rhamnosus is a probiotic, which enhances the immune response also serves as a source of macro- and micronutrients, contributes to enzymatic digestion, modifies toxin receptors, and manages toxin-mediated disease. It also acts as an antibacterial which inhibits both gram-positive and gram-negative enteric bacteria. Additionally, manages the colonization of harmful bacteria by competitively inhibiting microbial adhesion sites.

    Always take Vizylac GG Sachet as advised by the physician. The contents of the sachet can be consumed directly or can be mixed with lukewarm water and consumed. When taking antibiotics, use Vizylac GG Sachet at least 2 hours before or after taking antibiotics. It should not be taken by patients with bowel perforation (hole in the intestine) or patients at risk of bowel perforation or severely immunocompromised individuals.

    Key Composition

    • Lactobacillus Rhamnosus

    Therapeutic Uses Of VIZYLAC GG SACHET

    • Prevents and manages acute infectious diarrhoea, antibiotic-associated diarrhoea and travellers diarrhoea
    • Relieves symptoms of irritable bowel syndrome, ulcerative colitis and Crohn's disease
    • Manage atopic dermatitis in children
    • Prevents and manages diarrhea caused by rotavirus in babies and children
    • Manage colic in babies

    Side Effects Of VIZYLAC GG SACHET

    Vizylac GG Sachet may cause flatulence and mild abdominal discomfort in some individuals. Consult your doctor if you notice any such effects while taking Vizylac GG Sachet.

    Safety Advice

    • Always take Vizylac GG Sachet as advised by your physician
    • Adults should take 1-2 Vizylac GG Sachets daily or as directed by your doctor. For children administer one-half to one sachet per day
    • The contents of the sachet can be consumed directly or can be mixed with 15 ml of lukewarm water and consumed. For children open the sachet and stir the contents into a cool drink or mix into baby food or applesauce
    • When taking antibiotics, use Vizylac GG Sachet at least 2 hours before or after taking antibiotics
    • Do not use Vizylac GG Sachet if you are allergic to any of its ingredients
    • Inform your doctor if you are pregnant or breastfeeding women before taking Vizylac GG Sachet
    • Vizylac GG Sachet should not be taken by patients with bowel perforation (hole in the intestine) or patients at risk of bowel perforation or in severe immunocompromised states
    • Vizylac GG Sachet should be taken with caution in patients with diarrhoea lasting for more than 2 days accompanied by fever, weakened immune system (because of chemotherapy or HIV infection), diabetes, phenylketonuria (PKU), short gut syndrome (condition in which body is unable to absorb nutrients from food), recurring vaginal and urinary tract infection
    • Inform your doctor if you are taking or have recently taken any other medicines including prescription and over-the-counter medications, as well as a vitamin supplement or herbal products

    More Information

    • Keep Vizylac GG Sachet out of the reach and sight of children
    • Store at a temperature below 25°C

    FAQs About VIZYLAC GG SACHET

    Q: What is the use of Vizylac GG Sachet?

    A: Vizylac GG Sachet is a probiotic, used to manage diarrhoea, antibiotic-associated diarrhoea, diarrhea caused by rotavirus (in babies and children) and travellers’ diarrhoea. It is also used to relieve symptoms such as irritable bowel syndrome (IBS), Crohn's disease and ulcerative colitis. Also, it is used to manage colic in babies and atopic dermatitis in children. 

    Q: How does Vizylac GG Sachet work?

    A: Lactobacillus Rhamnosus is a probiotic, which enhances the immune response also serves as a source of macro- and micronutrients, contributes enzymatic digestion, modifies toxin receptors and manages toxin-mediated disease. It also acts as an antibacterial which inhibits both gram-positive and gram-negative enteric bacteria. Additionally, manages the colonization of harmful bacteria by competitively inhibiting microbial adhesion sites.

    Q: How to use Vizylac GG Sachet?

    A: The contents of the sachet can be consumed directly or can be mixed with 15 ml of lukewarm water and consumed. For children open the sachet and stir the contents into a cool drink or mix into baby food or applesauce.

    Q: What are the side effects of Vizylac GG Sachet?

    A: Vizylac GG Sachet may cause flatulence and mild abdominal discomfort in some individuals. Consult your doctor if you notice any such effects while taking Vizylac GG Sachet.

    Q: Who should use Vizylac GG Sachet with caution?

    A: Vizylac GG Sachet should be taken with caution in patients with diarrhoea lasting for more than 2 days accompanied by fever, weakened immune system (because of chemotherapy or HIV infection), diabetes, phenylketonuria (PKU), short gut syndrome (a condition in which body is unable to absorb nutrients from food), recurring vaginal and urinary tract infection.

    References

    1. https://www.centaurpharma.com/downloads/entchestphysician/dairrhoea/Enterolife%20GG.pdf

    2. https://www.torrentian.com/pisheet/Upload/PI_Sheet/Abbreviated_PI/2824.pdf

    3. https://www.drugs.com/mtm/lactobacillus-rhamnosus-gg.html

    Author Details

    Written By Dr. R. Dinesh John Rajkumar - Pharm.D
    Reviewed For Accuracy By Dr. Narayanasetty Sai Swaroop - Pharm.D
    Last updated on 18 Feb 2023 | 06:22 PM(IST)
    Lab updated